000 | 01856 a2200517 4500 | ||
---|---|---|---|
005 | 20250512101247.0 | ||
264 | 0 | _c19691105 | |
008 | 196911s 0 0 eng d | ||
022 | _a0008-543X | ||
024 | 7 |
_a10.1002/1097-0142(196910)24:4<719::aid-cncr2820240409>3.0.co;2-a _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCupps, R E | |
245 | 0 | 0 |
_aTreatment of pulmonary metastatic disease with radiation therapy and adjuvant actinomycin D. Preliminary observations. _h[electronic resource] |
260 |
_bCancer _cOct 1969 |
||
300 |
_a719-23 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
650 | 0 | 4 |
_aCobalt Isotopes _xtherapeutic use |
650 | 0 | 4 |
_aDactinomycin _xadverse effects |
650 | 0 | 4 |
_aEpendymoma _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrosarcoma _xdrug therapy |
650 | 0 | 4 |
_aHemangiopericytoma _xdrug therapy |
650 | 0 | 4 |
_aHemangiosarcoma _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Parenteral |
650 | 0 | 4 |
_aLiposarcoma _xdrug therapy |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMesenchymoma _xdrug therapy |
650 | 0 | 4 |
_aOsteosarcoma _xdrug therapy |
650 | 0 | 4 | _aRadiotherapy Dosage |
650 | 0 | 4 | _aRadiotherapy, High-Energy |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aRhabdomyosarcoma _xdrug therapy |
650 | 0 | 4 |
_aSarcoma _xdrug therapy |
650 | 0 | 4 |
_aSarcoma, Ewing _xdrug therapy |
650 | 0 | 4 |
_aSarcoma, Synovial _xdrug therapy |
650 | 0 | 4 |
_aTeratoma _xdrug therapy |
700 | 1 | _aAhmann, D L | |
700 | 1 | _aSoule, E H | |
773 | 0 |
_tCancer _gvol. 24 _gno. 4 _gp. 719-23 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(196910)24:4<719::aid-cncr2820240409>3.0.co;2-a _zAvailable from publisher's website |
999 |
_c4314704 _d4314704 |